Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 147 INDUSTRY 106 NETWORK 21 NIH 5 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Cisplatin 50 Capecitabine 42 apatinib 34 Radiotherapy 33 Oxaliplatin 33 Gemcitabine 33 Cyclophosphamide 32 Drug Therapy 31 Paclitaxel 30 Carboplatin 29 tislelizumab 27 Irinotecan 27 Fluorouracil 26 Docetaxel 26 Bevacizumab 23 Surgical Procedures, Operative 21 Nivolumab 19 pembrolizumab 18 fludarabine 18 Radiation 16 Metformin 16 Exercise 16 camrelizumab 15 S 1 (combination) 14 Control Groups 14 Blood Specimen Collection 14 Pemetrexed 13 Standard of Care 12 anlotinib 11 Neoadjuvant Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × daratumumab × Clear all

NCT04065789 2022-01-27

KyDaR

Tel-Aviv Sourasky Medical Center

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡